3UBB

The crystal structure of GlpG in complex with a phosphonofluoridate inhibitor

3UBB の概要

• エントリーDOI: 10.2210/pdb3ubb/pdb
• 分子名称: Rhomboid protease glpG, propan-2-yl hydrogen (S)-[(1R)-1-{[(benzyloxy)carbonyl]amino}ethyl]phosphonate (3 entities in total)
• 機能のキーワード: helix bundle, membrane, hydrolase-inhibitor complex, hydrolase/inhibitor
• 由来する生物種: Escherichia coli
• タンパク質・核酸の鎖数: 1
• 化学式量合計: 20829.59

構造登録者

Xue, Y.,Ha, Y. (登録日: 2011-10-24, 公開日: 2012-06-13, 最終更新日: 2024-10-30)

主引用文献

Xue, Y.,Chowdhury, S.,Liu, X.,Akiyama, Y.,Ellman, J.,Ha, Y.
Conformational Change in Rhomboid Protease GlpG Induced by Inhibitor Binding to Its S' Subsites.
Biochemistry, 51:3723-3731, 2012

PubMed Abstract: Rhomboid protease conducts proteolysis inside the hydrophobic environment of the membrane. The conformational flexibility of the protease is essential for the enzyme mechanism, but the nature of this flexibility is not completely understood. Here we describe the crystal structure of rhomboid protease GlpG in complex with a phosphonofluoridate inhibitor, which is covalently bonded to the catalytic serine and extends into the S' side of the substrate binding cleft. Inhibitor binding causes subtle but extensive changes in the membrane protease. Many transmembrane helices tilt and shift positions, and the gap between S2 and S5 is slightly widened so that the inhibitor can bind between them. The side chain of Phe-245 from a loop (L5) that acts as a cap rotates and uncovers the opening of the substrate binding cleft to the lipid bilayer. A concurrent turn of the polypeptide backbone at Phe-245 moves the rest of the cap and exposes the catalytic serine to the aqueous solution. This study, together with earlier crystallographic investigation of smaller inhibitors, suggests a simple model for explaining substrate binding to rhomboid protease.

PubMed: 22515733
DOI: 10.1021/bi300368b

実験手法

X-RAY DIFFRACTION (2.601 Å)